Key Highlights

  • Donegal Group (NASDAQ:DGICB) reports third quarter 2026 results on October 29, before the Nasdaq open, with a webcast at about 8:30 a.m. ET, after a 41.23% monthly rise and a 7.67% fall in the latest session.
  • PacBio (NASDAQ:PACB) reports third quarter results on November 4, 2026 after an 82.19% monthly rally, with second quarter revenue of USD 39.0 million and full-year guidance of USD 155 million to USD 165 million.
  • Rapid7 (NASDAQ:RPD) reports on November 4, 2026 with a call at 4:30 p.m. ET after a 61.01% monthly gain, and full-year revenue guidance is USD 837 million to USD 841 million.
  • Black Rock Coffee Bar (NASDAQ:BRCB) holds its third quarter call on November 10, 2026 at 5:00 p.m. ET after a 41.94% monthly rise, with second quarter revenue of USD 63.00 million and EPS of USD 0.06.

Donegal Group (NASDAQ:DGICB): Reports October 29 before the open

Donegal Group (NASDAQ:DGICB) announced no acquisition, guidance change or financing in the past month, so the 41.23% rise is unexplained. A published summary shows a close of USD 25.56 on October 27, and the latest data show a 7.67% fall to USD 23.60, so the stock gave back part of the gain the day before results. The shares are up 20.96% over a week, 12.80% over three months and 36.50% year to date. The largest single-day move in the past year was a 30% rise on June 16, 2026, which shows the stock can gap sharply. The cause of the monthly rise is therefore not established. Insiders were also active in September, including a 10% owner purchase of about 16,000 shares, which does not explain the rise but shows interest. Donegal Group is an insurance holding company whose subsidiaries write property and casualty insurance in 21 states across the Mid-Atlantic, Midwest, South and Southwest, in commercial lines such as commercial auto and workers' compensation and personal lines such as auto and homeowners. With Donegal Mutual Insurance Company it forms the Donegal Insurance Group, rated A (Excellent) by A.M. Best. For 2025 revenue was USD 978.0 million and net income was USD 79.3 million, an 8.1% margin.

PacBio (NASDAQ:PACB): Reports November 4 after a rally

The rally at PacBio (NASDAQ:PACB) came from partner news built on its HiFi long-read sequencing, not from a company earnings release. EpiSign launched METRIC 5-base software for DNA methylation analysis on PacBio HiFi data on September 30, 2026, and on October 5 EpiSign and Geneyx Genomex announced a partnership extending episignature analysis for over 300 disorders. On October 20 PacBio announced a multi-year collaboration with Verily Health to build AI-ready clinico-genomic datasets, and TychoBio will sequence over 10,000 samples for RNA therapy design. No company announcement explains the 18.98% gain on October 28. EpiSign's software also supports Illumina and Oxford Nanopore data, so the partner news is not exclusive. A Sampled contract with the U.S. Department of Veterans Affairs worth up to USD 27.1 million over five years had also moved the shares two days earlier, as reported. In the second quarter of 2026, reported on August 5, revenue was USD 39.0 million versus USD 39.8 million a year earlier, with consumables up to USD 20.1 million and instruments down to USD 12.8 million. The GAAP net loss was USD 44.7 million, GAAP gross margin fell to 32% from 37%, and Vega placements dropped to 26 from 38 while Revio placements rose to 20. The company cited higher compute and memory costs and Vega manufacturing transition costs. The SPRQ-Nx chemistry rollout lists whole genome sequencing at USD 345 per genome.

Rapid7 (NASDAQ:RPD): Reports November 4 with set guidance

Rapid7 (NASDAQ:RPD) released no acquisition, activist or guidance news in its own items from September 3 to October 21, 2026. Those items are conference appearances, inducement grants of 290,626 and 455,621 restricted stock units, the October 2 launch of Rapid7 Intelligence, and a threat report on October 21 finding that AI played a role in 8% of incidents. One analyst firm, JPMorgan, reiterated an underweight rating with a USD 12 target on September 15, below the latest USD 17.92 quote. The cause of the 61.01% gain is therefore not established. The same report said human operators still drive most tracked attacks. Nothing in those items mentions takeover interest or a strategic review. Rapid7 (NASDAQ:RPD) is a cybersecurity company. In the second quarter it reported adjusted EPS of USD 0.44, revenue of USD 210.88 million and a restructuring affecting about 12% of the workforce. Guidance for 2026 is revenue of USD 837 million to USD 841 million and non-GAAP operating income of USD 129 million to USD 133 million, and third quarter EPS guidance is USD 0.44 to USD 0.47. Revenue is down 1.5% year over year, so growth is flat, while margins improved after cost cuts.

Black Rock Coffee Bar (NASDAQ:BRCB): Reports November 10 after a rebound

Black Rock Coffee Bar (NASDAQ:BRCB) has announced no deal, guidance change or financing in the past month, and the gain follows a long decline from a 52-week high of USD 26.48. The shares are down 54.66% year to date and 61.11% over one year, so the 41.94% monthly rise is a rebound from depressed levels. Reported analyst actions were negative or neutral: Morgan Stanley cut to equal weight on July 15 with a USD 9 target, down from USD 22, and DA Davidson lowered its target to USD 10 from USD 15 on August 12. A quantitative research rating was cut to Strong Sell on October 17. The cause of the rebound is therefore not established. Black Rock Coffee Bar (NASDAQ:BRCB) operates drive-thru and café specialty coffee shops, was founded in 2008 by Jeff Hernandez and Daniel Brand, and is headquartered in Portland, Oregon. In the second quarter, reported on August 11, 2026, revenue was USD 63.00 million and earnings per share of USD 0.06 missed the USD 0.07 consensus. Analysts forecast earnings of USD 0.21 per share for the year. Net margin is thin at 0.69%, and the price to earnings ratio was about 104 in early October, as reported, which leaves the valuation sensitive to store growth and same-store sales.

Where Things Stand

The answer is that the next two weeks bring four reports, and each stock enters them after a large monthly gain. Donegal Group (NASDAQ:DGICB) reports first on October 29, 2026, then PacBio and Rapid7 on November 4, and Black Rock Coffee Bar on November 10. Expectations are higher after the rallies, so a miss could reverse gains, and the evidence for fundamental improvement is mixed. Further disclosure from Black Rock Coffee Bar (NASDAQ:BRCB) would clarify the picture.